Does the use of insulin faster aspart vs. aspart lead to the prolonged glycemic time in range in children with type 1 diabetes who use continuous glucose monitoring?

被引：0
|
作者：
Kowalczyk-Korcz, E. [1 ]
Dyminska, M. [1 ]
Szypowska, A. [1 ]
机构：
[1] Med Univ Warsaw, Dept Pediat Diabetol & Pediat, Warsaw, Poland
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2024年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-75
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [31] Higher Early Exposure and Greater Early Glucose-lowering Effect with Faster-Acting Insulin Aspart vs. Insulin Aspart in Japanese Patients with T1D
    Shiramoto, Masanari
    Nishida, Tomoyuki
    Hansen, Ann Kathrine
    Haahr, Hanne
    DIABETES, 2015, 64 : A249 - A249
  • [32] Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus
    Seaquist, E. R.
    Blonde, L.
    McGill, J. B.
    Heller, S. R.
    Kendall, D. M.
    Bumpass, J. B.
    Pompilio, F. M.
    Grant, M. L.
    DIABETIC MEDICINE, 2020, 37 (05) : 752 - 759
  • [33] Improved time-in-range on continuous glucose monitor with Technosphere insulin compared to insulin Aspart in adults with type 1 diabetes: Stat study per protocol analysis
    Snell-Bergeon, J.
    Akturk, H. K.
    Beck, E. A.
    Klaff, L. J.
    Bode, B. W.
    Peters, A.
    Bailey, T. S.
    Garg, S. K.
    DIABETOLOGIA, 2018, 61 : S329 - S329
  • [34] Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial
    Shah, Viral N.
    Al-Karadsheh, Amer
    Barnes, Cathy
    Mandry, Jose
    Nakhle, Samer
    Wernicke-Panten, Karin
    Kramer, Daniel
    Schmider, Wolfgang
    Pierre, Suzanne
    Teichert, Lenore
    Rotthaeuser, Baerbel
    Mukherjee, Bhaswati
    Bailey, Timothy S.
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 540 - 547
  • [35] Use of Continuous Glucose Monitoring Systems in Children with Type 1 Diabetes
    Minnock, Pantea P.
    Howe, Carol J.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (02) : 273 - +
  • [36] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [37] In type 1 diabetes, real-time vs. intermittently scanned continuous glucose monitoring improved glycemic control
    Olson, Darin E.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (10) : JC119 - JC119
  • [38] CopenFast Trial-Fetal Growth and Glycemic Control in Pregnant Women with Type 1 or Type 2 Diabetes Using Faster-Acting Insulin Aspart or Insulin Aspart-A Randomized Controlled Trial
    Noergaard, Sidse K.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Soholm, Julie
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    DIABETES, 2023, 72
  • [39] The impact of of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump
    de Buitrago Amigo, Jesus Gonzalez
    Gonzalez Garcia, Ana
    Diaz Fernandez, Paula
    Fernandez Llamas, Mercedes
    Tejado Bravo, Maria Luz
    de Nicolas Jimenez, Jorge M.
    Ferrer Lozano, Marta
    ANALES DE PEDIATRIA, 2021, 95 (05): : 321 - 329
  • [40] Fast-acting insulin aspart in Japanese patients with type 1 diabetes: Faster onset, higher early exposure and greater early glucose-lowering effect relative to insulin aspart
    Shiramoto, Masanari
    Nishida, Tomoyuki
    Hansen, Ann Kathrine
    Haahr, Hanne
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 303 - 310
12345